The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Mechanisms of Anabolic Therapies for Osteoporosis
Abstract
Antiresorptive agents help to restore skeletal balance by reducing bone turnover, primarily at the tissue level. Another therapeutic approach is to enhance bone formation with the use of anabolic agents, which differ fundamentally from antiresorptive drugs in their primary mechanism of action. This article reviews the mechanisms of polypeptide anabolic agents and strontium as potential therapeutic options for osteoporosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neer, R. M., Arnaud, C. D., Zanchetta, J. R., Prince, R., Gaich, G. A., Reginster, J.-Y., Hodsman, A. B., Eriksen, E. F., Ish-Shalom, S., Genant, H. K., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105103441904 · Cited by 4,602
LDL Receptor-Related Protein 5 (LRP5) Affects Bone Accrual and Eye Development
Gong, Y., Slee, R. B., Fukai, N., Rawadi, G., Roman-Roman, S., Reginato, A. M., Wang, H., Cundy, T., Glorieux, F. H., Lev, D., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00571-2 · Cited by 2,235
Bone Quality — The Material and Structural Basis of Bone Strength and Fragility
Seeman, E., & Delmas, P. D. (2006) · New England Journal of Medicine · doi:10.1056/nejmra053077 · Cited by 2,080
Meunier, P. J., Roux, C., Seeman, E., Ortolani, S., Badurski, J. E., Spector, T. D., Cannata, J., Balogh, A., Lemmel, E.-M., Pors-Nielsen, S., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa022436 · Cited by 1,638
High Bone Density Due to a Mutation in LDL-Receptor–Related Protein 5
Boyden, L. M., Mao, J., Belsky, J., Mitzner, L., Farhi, A., Mitnick, M. A., Wu, D., Insogna, K., & Lifton, R. P. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013444 · Cited by 1,591
Secreted antagonists of the Wnt signalling pathway
Kawano, Y., & Kypta, R. (2003) · Journal of Cell Science · doi:10.1242/jcs.00623 · Cited by 1,584
Regulation of bone mass by Wnt signaling
Krishnan, V. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28551 · Cited by 1,407
Prevalence of low femoral bone density in older U.S. women from NHANES III
Looker, A. C., Johnston, C. C., Wahner, H. W., Dunn, W. L., Calvo, M. S., Harris, T. B., Heyse, S. P., & Lindsay, R. L. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650100517 · Cited by 1,379
Sclerostin Binds to LRP5/6 and Antagonizes Canonical Wnt Signaling
Li, X., Zhang, Y., Kang, H., Liu, W., Liu, P., Zhang, J., Harris, S. E., & Wu, D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413274200 · Cited by 1,366
Giustina, A., & Veldhuis, J. D. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.6.0353 · Cited by 1,253
Self-citationProteasome inhibitors: from research tools to drug candidates
Kisselev, A. F., & Goldberg, A. L. (2001) · Chemistry & Biology · doi:10.1016/s1074-5521(01)00056-4 · Cited by 1,184
Black, D. M., Greenspan, S. L., Ensrud, K. E., Palermo, L., McGowan, J. A., Lang, T. F., Garnero, P., Bouxsein, M. L., Bilezikian, J. P., & Rosen, C. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa031975 · Cited by 1,174
Self-citationIncreased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)
Balemans, W. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.5.537 · Cited by 1,147
Reginster, J. Y., Seeman, E., De Vernejoul, M. C., Adami, S., Compston, J., Phenekos, C., Devogelaer, J. P., Curiel, M. D., Sawicki, A., Goemaere, S., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1774 · Cited by 1,071
Prevalence of Low Femoral Bone Density in Older U.S. Adults from NHANES III
Looker, A. C., Orwoll, E. S., Johnston, C. C., Lindsay, R. L., Wahner, H. W., Dunn, W. L., Calvo, M. S., Harris, T. B., & Heyse, S. P. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.11.1761 · Cited by 1,051
Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone
Jilka, R. L., Weinstein, R. S., Bellido, T., Roberson, P., Parfitt, A. M., & Manolagas, S. C. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6610 · Cited by 1,043
Brunkow, M. E., Gardner, J. C., Van Ness, J., Paeper, B. W., Kovacevich, B. R., Proll, S., Skonier, J. E., Zhao, L., Sabo, P. J., Fu, Y.-H., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/318811 · Cited by 1,011
Regulation of osteoblastogenesis and bone mass by Wnt10b
Bennett, C. N., Longo, K. A., Wright, W. S., Suva, L. J., Lane, T. F., Hankenson, K. D., & MacDougald, O. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408742102 · Cited by 881
Bone Morphogenetic Proteins, Their Antagonists, and the Skeleton
Canalis, E., Economides, A. N., & Gazzerro, E. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0023 · Cited by 863
Self-citationThe Effects of Parathyroid Hormone, Alendronate, or Both in Men with Osteoporosis
Finkelstein, J. S., Hayes, A., Hunzelman, J. L., Wyland, J. J., Lee, H., & Neer, R. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035725 · Cited by 829
Anabolic Actions of Parathyroid Hormone on Bone*
DEMPSTER, D. W., COSMAN, F., PARISIEN, M., SHEN, V., & LINDSAY, R. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-6-690 · Cited by 717
Zhang, M., Xuan, S., Bouxsein, M. L., von Stechow, D., Akeno, N., Faugere, M. C., Malluche, H., Zhao, G., Rosen, C. J., Efstratiadis, A., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208265200 · Cited by 696
Dempster, D. W., Cosman, F., Kurland, E. S., Zhou, H., Nieves, J., Woelfert, L., Shane, E., Plavetić, K., Müller, R., Bilezikian, J., et al. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.10.1846 · Cited by 653
Self-citationBellido, T., Ali, A. A., Gubrij, I., Plotkin, L. I., Fu, Q., O’Brien, C. A., Manolagas, S. C., & Jilka, R. L. (2005) · Endocrinology · doi:10.1210/en.2005-0239 · Cited by 641
One Year of Alendronate after One Year of Parathyroid Hormone (1–84) for Osteoporosis
Black, D. M., Bilezikian, J. P., Ensrud, K. E., Greenspan, S. L., Palermo, L., Hue, T., Lang, T. F., McGowan, J. A., & Rosen, C. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050336 · Cited by 614
Self-citationCanalis, E., Centrella, M., Burch, W., & McCarthy, T. L. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113885 · Cited by 543
Self-citationSignal transduction by bone morphogenetic proteins
Kawabata, M. (1998) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(97)00036-1 · Cited by 528
Signal transduction of bone morphogenetic protein receptors
Nohe, A. (2004) · Cellular Signalling · doi:10.1016/j.cellsig.2003.08.011 · Cited by 514
The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro
Canalis, E. (1996) · Bone · doi:10.1016/8756-3282(96)00080-4 · Cited by 498
Self-citationMechanotransduction and strain amplification in osteocyte cell processes
Han, Y., Cowin, S. C., Schaffler, M. B., & Weinbaum, S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407429101 · Cited by 496
Differential Effects of Teriparatide on BMD After Treatment With Raloxifene or Alendronate
Ettinger, B., Martin, S. J., Crans, G., & Pavo, I. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040117 · Cited by 487
Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease
Loots, G. G., Kneissel, M., Keller, H., Baptist, M., Chang, J., Collette, N. M., Ovcharenko, D., Plajzer-Frick, I., & Rubin, E. M. (2005) · Genome Research · doi:10.1101/gr.3437105 · Cited by 442
Bone morphogenetic protein-3 is a negative regulator of bone density
Daluiski, A., Engstrand, T., Bahamonde, M. E., Gamer, L. W., Agius, E., Stevenson, S. L., Cox, K., Rosen, V., & Lyons, K. M. (2001) · Nature Genetics · doi:10.1038/83810 · Cited by 427
Greenspan, S. L., Bone, H. G., Ettinger, M. P., Hanley, D. A., Lindsay, R., Zanchetta, J. R., Blosch, C. M., Mathisen, A. L., Morris, S. A., Marriott, T. B., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-5-200703060-00005 · Cited by 427
Vahle, J. L., Long, G. G., Sandusky, G., Westmore, M., Ma, Y. L., & Sato, M. (2004) · Toxicologic Pathology · doi:10.1080/01926230490462138 · Cited by 376
Glucocorticoid-induced osteoporosis: an update
Mazziotti, G., Angeli, A., Bilezikian, J. P., Canalis, E., & Giustina, A. (2006) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2006.03.009 · Cited by 362
Self-citationGreenspan, S. L., Bone, H. G., Ettinger, M. P., Hanley, D. A., Lindsay, R. S., Zanchetta, J., Blosch, C. M., Mathisen, A. L., Morris, S. A., & Marriott, T. B. (2007) · Annals of Internal Medicine · Cited by 360
Zhao, G., Monier-Faugere, M.-C., Langub, M. C., Geng, Z., Nakayama, T., Pike, J. W., Chernausek, S. D., Rosen, C. J., Donahue, L.-R., Malluche, H. H., et al. (2000) · Endocrinology · doi:10.1210/endo.141.7.7585 · Cited by 359
Recker, R., Lappe, J., Davies, K. M., & Heaney, R. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040710 · Cited by 343
Bone morphogenetic proteins and their antagonists
Gazzerro, E., & Canalis, E. (2007) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-006-9000-6 · Cited by 338
Self-citationGrinspoon, S., Thomas, L., Miller, K., Herzog, D., & Klibanski, A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.6.8574 · Cited by 334
Selective inhibitors of the osteoblast proteasome stimulate bone formation in vivo and in vitro
Garrett, I. R., Chen, D., Gutierrez, G., Zhao, M., Escobedo, A., Rossini, G., Harris, S. E., Gallwitz, W., Kim, K. B., Hu, S., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16198 · Cited by 328
Murray, T. M., Rao, L. G., Divieti, P., & Bringhurst, F. R. (2005) · Endocrine Reviews · doi:10.1210/er.2003-0024 · Cited by 316
Gowen, M., Stroup, G. B., Dodds, R. A., James, I. E., Votta, B. J., Smith, B. R., Bhatnagar, P. K., Lago, A. M., Callahan, J. F., DelMar, E. G., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9038 · Cited by 279
Insulin receptor substrate-1 in osteoblast is indispensable for maintaining bone turnover
Ogata, N., Chikazu, D., Kubota, N., Terauchi, Y., Tobe, K., Azuma, Y., Ohta, T., Kadowaki, T., Nakamura, K., & Kawaguchi, H. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9017 · Cited by 271
Grinspoon, S. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.11.3864 · Cited by 258
Langlois, J. A., Rosen, C. J., Visser, M., Hannan, M. T., Harris, T., Wilson, P. W. F., & Kiel, D. P. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.12.5308 · Cited by 255
Daily and Cyclic Parathyroid Hormone in Women Receiving Alendronate
Cosman, F., Nieves, J., Zion, M., Woelfert, L., Luckey, M., & Lindsay, R. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050157 · Cited by 250
Deal, C., Omizo, M., Schwartz, E. N., Eriksen, E. F., Cantor, P., Wang, J., Glass, E. V., Myers, S. L., & Krege, J. H. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050714 · Cited by 223
Strontium ranelate: A physiological approach for optimizing bone formation and resorption
Marie, P. J. (2006) · Bone · doi:10.1016/j.bone.2005.07.029 · Cited by 202
Seeman, E., Vellas, B., Benhamou, C., Aquino, J. P., Semler, J., Kaufman, J. M., Hoszowski, K., Varela, A. R., Fiore, C., Brixen, K., et al. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060404 · Cited by 200
Horwitz, M. J., Tedesco, M. B., Gundberg, C., Garcia-Ocana, A., & Stewart, A. F. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021122 · Cited by 187
Ghiron, L. J., Thompson, J. L., Holloway, L., Hintz, R. L., Butterfield, G. E., Hoffman, A. R., & Marcus, R. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650101203 · Cited by 180
Bone Mineral Density in Sclerosteosis; Affected Individuals and Gene Carriers
Gardner, J. C., van Bezooijen, R. L., Mervis, B., Hamdy, N. A. T., Löwik, C. W. G. M., Hamersma, H., Beighton, P., & Papapoulos, S. E. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1235 · Cited by 178
The Bone Remodeling Compartment: A Circulatory Function for Bone Lining Cells
Parfitt, A. M. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.9.1583 · Cited by 169
Black, D. M., Greenspan, S. L., Ensrud, K. E., Palermo, L., McGowan, J. A., Lang, T. F., Garnero, P., Bouxsein, M. L., Bilezikian, J. P., & Rosen, C. J. (2004) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000115856.54444.d6 · Cited by 159
Self-citationChen, P., Miller, P. D., Delmas, P. D., Misurski, D. A., & Krege, J. H. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060802 · Cited by 158
Van Buchem Disease (Hyperostosis Corticalis Generalisata) Maps to Chromosome 17q12-q21
Van Hul, W., Balemans, W., Van Hul, E., Dikkers, F. G., Obee, H., Stokroos, R. J., Hildering, P., Vanhoenacker, F., Van Camp, G., & Willems, P. J. (1998) · The American Journal of Human Genetics · doi:10.1086/301721 · Cited by 158
Evidence That Anabolic Effects of PTH on Bone Require IGF-I in Growing Mice
Miyakoshi, N., Kasukawa, Y., Linkhart, T. A., Baylink, D. J., & Mohan, S. (2001) · Endocrinology · doi:10.1210/endo.142.10.8436 · Cited by 155
Gaddy-Kurten, D., Coker, J., Abe, E., Jilka, R. L., & Manolagas, S. C. (2002) · Endocrinology · doi:10.1210/endo.143.1.8580 · Cited by 145
Jolette, J., Wilker, C. E., Smith, S. Y., Doyle, N. E., Hardisty, J. F., Metcalfe, A. J., Marriott, T. B., Fox, J., & Wells, D. S. (2006) · Toxicologic Pathology · doi:10.1080/01926230601072301 · Cited by 144
Mazziotti, G., Bianchi, A., Bonadonna, S., Nuzzo, M., Cimino, V., Fusco, A., De Marinis, L., & Giustina, A. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060112 · Cited by 141
Self-citationHodsman, A. B., Kisiel, M., Adachi, J. D., Fraher, L. J., & Watson, P. H. (2000) · Bone · doi:10.1016/s8756-3282(00)00316-1 · Cited by 134
Langlois, J. A. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.12.4257 · Cited by 130
The anabolic effects of parathyroid hormone therapy
Rubin, M. R., & Bilezikian, J. P. (2003) · Clinics in Geriatric Medicine · doi:10.1016/s0749-0690(02)00074-5 · Cited by 123
Self-citationOsteosarcoma and Teriparatide?
Harper, K. D., Krege, J. H., Marcus, R., & Mitlak, B. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.061111 · Cited by 120
Zhao, G. (2000) · Endocrinology · doi:10.1210/en.141.7.2674 · Cited by 94
Insulin Receptor Substrate-1 Is Required for Bone Anabolic Function of Parathyroid Hormone in Mice
Yamaguchi, M., Ogata, N., Shinoda, Y., Akune, T., Kamekura, S., Terauchi, Y., Kadowaki, T., Hoshi, K., Chung, U., Nakamura, K., et al. (2005) · Endocrinology · doi:10.1210/en.2004-1511 · Cited by 90
Oral Delivery of Biologically Active Parathyroid Hormone
Leone‐Bay, A., Sato, M., Paton, D. R., Hunt, A. H., Sarubbi, D., Carozza, M., Chou, J., McDonough, J., & Baughman, R. (2001) · Pharmaceutical Research · doi:10.1023/a:1010936227570 · Cited by 87
Centrella, M., McCarthy, T. L., & CANALIS, E. M. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.1.250-258.1991 · Cited by 77
Self-citationThe Fate of Circulating Osteoblasts
CANALIS, E. M. (2005) · New England Journal of Medicine · doi:10.1056/nejme058080 · Cited by 74
Self-citationOne Year of Alendronate After One Year of Parathyroid Hormone (1???84) for Osteoporosis
Black, D. M., Bilezikian, J. P., Ensrud, K. E., Greenspan, S. L., Palermo, L., Hue, T. F., Lang, T., McGowan, J., & Rosen, C. J. (2005) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000193859.78235.fe · Cited by 64
Self-citationIida‐Klein, A., Lu, S. S., Cosman, F., Lindsay, R., & Dempster, D. W. (2006) · Bone · doi:10.1016/j.bone.2006.09.010 · Cited by 37
Pickard, B. W., Hodsman, A. B., Fraher, L. J., & Watson, P. H. (2006) · Endocrinology · doi:10.1210/en.2005-1408 · Cited by 36
Initial experience with teriparatide in the United States
Gold, D. T., Pantos, B., Masica, D. N., Misurski, D. A., & Marcus, R. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x100159 · Cited by 30
Skeletal actions of insulin-like growth factors
Gazzerro, E., & CANALIS, E. M. (2006) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.1.1.47 · Cited by 24
Self-citationCurrent Guidelines for Adult GH Replacement
Doga, M., Bonadonna, S., Gola, M., Solerte, S. B., Amato, G., Carella, C., & Giustina, A. (2005) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-005-5226-y · Cited by 24
Self-citation
Cited by
Osteoporosis: now and the future
Rachner, T. D., Khosla, S., & Hofbauer, L. C. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62349-5 · Cited by 2,696
Fracture healing: mechanisms and interventions
Einhorn, T. A., & Gerstenfeld, L. C. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.164 · Cited by 1,807
Osteoporosis treatment: recent developments and ongoing challenges
Khosla, S., & Hofbauer, L. C. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30188-2 · Cited by 1,019
Growth Hormone, Insulin-Like Growth Factors, and the Skeleton
Giustina, A., Mazziotti, G., & Canalis, E. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0036 · Cited by 914
Self-citationCalcium phosphates in biomedical applications: materials for the future?
Habraken, W., Habibovic, P., Epple, M., & Bohner, M. (2016) · Materials Today · doi:10.1016/j.mattod.2015.10.008 · Cited by 857
Metadata
- Authors
- Canalis, E., Giustina, A., & Bilezikian, J. P.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2007-08-30
- Volume
- 357
- Issue
- 9
- Pages
- 905-916
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2139785110
- Cited by
- 668
- References
- 77
- FWCI
- 45.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.